•   
  •   
  •   

Canada Coronavirus: Controversial malaria drug hydroxychloroquine tested at B.C. seniors’ home

08:35  28 march  2020
08:35  28 march  2020 Source:   globalnews.ca

Another ‘Games of Thrones’ star has tested positive for coronavirus

  Another ‘Games of Thrones’ star has tested positive for coronavirus Indira Varma, who played the wildly fierce Ellaria Sand on “Game of Thrones,” is reportedly hunkered down at home with the coronavirus. “I’m in bed with it and it’s not nice. Stay safe and healthy and be kind to your fellow people,” she wrote in an Instagram post. The actress, who also has credits in “Luther” and “Carnival Row,” is currently starring alongside fellow “Game of Thrones” alum Emilia Clark in the West End production of The Seagull by Anton Checkhov. The 46-year-old HBO star also expressed disappointment the production was put on hold amid the outbreak and encouraged fans to keep an eye out for its return.

Like chloroquine, hydroxychloroquine is used to treat rheumatoid arthritis and lupus, and is also Chloroquine has been used to treat malaria for many years, but it stopped working against malaria Chloroquine and hydroxychoroquine have been tested against the novel coronavirus both in the lab

A drug developed over half a century ago to treat malaria is showing signs that it may also help cure COVID-19 -- especially when combined with an antibiotic, a All six of them tested negative at day six. “Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly

a car parked on the side of a building: The Lynn Valley Care Centre is participating in an international study on the effectiveness of anti-malaria drug hydroxychloroquine against COVID-19. © Google Street View The Lynn Valley Care Centre is participating in an international study on the effectiveness of anti-malaria drug hydroxychloroquine against COVID-19.

A controversial anti-malaria drug is being trialed as a therapy for COVID-19 at the B.C. seniors' care home at the epicentre of the province's novel coronavirus outbreak.

Global News has confirmed that residents of the Lynn Valley Care Centre are receiving hydroxychloroquine as a part of an international study on the effectiveness of the drug.

Forty-six residents and 24 staff at the facility have have tested positive for COVID-19.

Toronto paramedic, homeless person among active coronavirus cases in city

  Toronto paramedic, homeless person among active coronavirus cases in city Included in the new cases, TPH said are a resident of a long-term city-run care home, a Toronto paramedic and a person experiencing homelessness. READ MORE: Coronavirus: Toronto epidemiologist modelling COVID-19 says the school year may be done Health officials said they are reaching out to those who may have been in close contact with each new case. The paramedic is currently in self-isolation.

To treat malaria : Hydroxychloroquine is usually given for 3 days, starting with one high dose You may be told to induce vomiting right away (at home , before transport to an emergency room). What other drugs will affect hydroxychloroquine ? Hydroxychloroquine can cause serious liver or heart

Hydroxychloroquine , an antimalarial drug dubbed a 'gift from God' by U.S. President Donald Trump for its potential ability to fight the new coronavirus , was found to be no more effective than standard treatment in a small Chinese study.

READ MORE: Can ebola, HIV or malaria drugs stop coronavirus? WHO starts testing to find out

The drug is being administered to all residents of the virus-stricken building known as "the lodge" at the care home, with the exception of those who opted out of the trial.

Debra Drew, whose father is one of the COVID-19-positive residents of the facility, said her family decided to opt in.

"As a family we had the right to deny the treatment," she said.

"We said, 'Yes, lets try it... Every day is a new day."

Hydroxychloroquine is a Health Canada-approved drug which has been used to treat malaria for more than a half-century. It is also used as a treatment for lupus.

READ MORE: Quebec-based pharmaceutical company donates 1 million doses of malaria-drug for COVID-19 patients across Canada

Ontario confirms 45 new coronavirus cases, province at 402 active

  Ontario confirms 45 new coronavirus cases, province at 402 active Ontario health officials announced 45 new cases of coronavirus, and one more resolved cased, bringing the total number of active cases in the province to 402. There has also been six cases resolved and three deaths, a 77-year-old man from Barrie, another man in his 70s in Barrie and a 51-year-old man from Halton Region.READ MORE: Coronavirus: Police lay out consequences if Ontario emergency orders aren’t followed Only 16 of the new cases have information, with the rest listed as pending. A man in his 40s, who travelled to England and is from the Simcoe Muskoka area is currently hospitalized.

Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine.

Antimalarial drugs chloroquine phosphate and hydroxychloroquine have both shown early signs of improving symptoms of some patients diagnosed with Covid-19, the respiratory disease caused by the coronavirus , based on reports by doctors and researchers in South Korea, France and China.

The drug made international headlines this month when U.S. President Donald Trump touted it as a potential breakthrough treatment for COVID-19.

The drug has shown promise in some small, early trials.

However, its benefits remain unproven, and the B.C. Centre for Disease Control (BCCDC) has recommended against its use to treat the disease "based on the lack of clinically convincing outcomes and the fragility of the supply chain."

On Thursday, the College of Pharmacists of BC, College of Physicians and Surgeons of BC, and BC College of Nursing Professionals took the unusual step of issuing a joint statement warning against the use of unproven treatments, including hydroxychloroquine.

READ MORE: Don’t trust Trump’s coronavirus ‘cure,’ says widow of man poisoned by chloroquine

However, that guidance specifically exempted clinical trials.

Hydroxychloroquine is also being tested by a team at the University of Manitoba.

Trials began March 26 in Manitoba and Quebec, and similar trials are also underway in the United States. Alberta and other provinces are expected to join within a few days.

— With files from Keith Baldrey, Sarah MacDonald and Sam Thompson

Canada takes cautious approach to unapproved COVID-19 drugs, as others prescribe wide use .
Canada takes cautious approach to unapproved COVID-19 drugs, as others prescribe wide useThe malaria drug hydroxychloroquine is a hot item in the United States, embraced by the highest politician in the land and many in the medical community, despite minimal evidence that it helps those stricken by the novel coronavirus.

—   Share news in the SOC. Networks
usr: 20
This is interesting!